Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.
D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002464:Cell Migration Inhibition; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D005455:Fluorescent Antibody Technique; D006801:Humans; D006968:Hypersensitivity, Delayed; D007110:Immunity, Active; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm; D001500:BCG Vaccine